Alprazolam Tablets recall: CGMP Deviations
Alprazolam Tablets, USP 1mg, 180-count bottles, Rx only, Manufactured by ULTRAlab Laboratories, Inc., NY; Packaged by GSMS, Inc., CA NDC 60429-504-18.
Why was Alprazolam Tablets recalled?
CGMP Deviation: Potential cross-contamination with other drug substance during the manufacturing process.
What should I do if I have this product?
Review the official FDA enforcement record for current instructions.
What to do with a recalled product: refunds, receipts, safe disposal and how to report a problem.
Is my product affected?
Compare the item in your hand with every identifier below from the official FDA record. Only products that match the listed product and lot, UPC or model codes are part of this recall.
Which lot codes, UPCs or models are affected?
Lot #: GS027852, Expiry: 06/2022.
- Product
- Alprazolam Tablets, USP 1mg, 180-count bottles, Rx only, Manufactured by ULTRAlab Laboratories, Inc., NY; Packaged by GSMS, Inc., CA NDC 60429-504-18.
- Recalling firm
- Golden State Medical Supply Inc.
- Quantity
- 401 bottles
- Distribution
- Distributed to 1 wholesaler/distributor
- Recall date
- March 23, 2022
- Classification
- Class II
- Status
- Terminated
- Agency
- FDA (drug)